Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.3%

4 terminated out of 48 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

21%

10 trials in Phase 3/4

Results Transparency

25%

4 of 16 completed with results

Key Signals

4 with results80% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (13)
P 1 (1)
P 2 (5)
P 3 (5)
P 4 (5)

Trial Status

Completed16
Recruiting13
Unknown9
Active Not Recruiting5
Terminated4
Enrolling By Invitation1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (48)

Showing 20 of 20 trials
NCT03568890Phase 4Active Not Recruiting

Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

NCT07491744Not ApplicableEnrolling By Invitation

The Stroke Aetiology and VascuLar Disease in Stroke and TIA Study - A Clinical Study Analysing the Effects on Cardiovascular Health and Disease With an Extended Investigation Into Conditions Causative of Stroke and Concomitant Cardiovascular Disease in Patients Admitted for Acute Stroke or TIA

NCT05529901Active Not Recruiting

Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder

NCT06605014Recruiting

Somatic Dysfunction in Patients With Acute Cerebrovascular Disease

NCT05476991Phase 3Recruiting

Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

NCT03749057Phase 4Completed

Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation

NCT06986954Recruiting

Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study

NCT05975554Not ApplicableActive Not RecruitingPrimary

The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.

NCT05518305Recruiting

Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis

NCT05378490Recruiting

The Akershus Study of Ischemic Stroke and Thrombolysis -1

NCT06785740Recruiting

Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study

NCT05476081Completed

A REAl-life Study on Short-term DAPT in Patients With Ischemic Stroke or TIA

NCT06495073Recruiting

Determining the MCID for the TOPICS-SF and PROMIS-10 in Older Patients That Suffered an Ischemic Stroke or TIA

NCT06315192Not ApplicableRecruiting

Stroke Alarm Efficacy Trial

NCT05134454Not ApplicableRecruiting

Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events

NCT00642213Active Not Recruiting

A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites

NCT06522113Phase 4Completed

Cilostazol and Aspirin in Stroke and TIA

NCT06225752Phase 3Recruiting

Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

NCT06319846Phase 3Recruiting

Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)

NCT05439356Phase 3Completed

Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

Scroll to load more

Research Network

Activity Timeline